Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study - Wikidata - awgldk - TriplyDB

Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study

Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study

http://www.wikidata.org/entity/Q56995088

about

First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies Multiple myeloma First line vs delayed transplantation in myeloma: Certainties and controversies Fifty years of melphalan use in hematopoietic stem cell transplantation Multiple myeloma: 2014 Update on diagnosis, risk-stratification, and management Advances in the autologous and allogeneic transplantation strategies for multiple myeloma Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma.Salvage second hematopoietic cell transplantation in myeloma Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial How we manage autologous stem cell transplantation for patients with multiple myeloma Bortezomib and melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma.Proteasome inhibition and its therapeutic potential in multiple myeloma Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial.Prognostic factor analyses of myeloma survival with intergroup trial S9321 (INT 0141): examining whether different variables govern different time segments of survival.Clinical challenges associated with bortezomib therapy in multiple myeloma and Waldenströms Macroglobulinemia Haematopoietic stem cell transplantation as first-line treatment in myeloma: a global perspective of current concepts and future possibilities Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma.International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable disease Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma.Outcomes of unrelated cord blood transplantation in patients with multiple myeloma: a survey on behalf of Eurocord, the Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, and the Chronic Leukemia Working Party of the EBMT.Targeting the proteasome with bortezomib in multiple myeloma: update on therapeutic benefit as an upfront single agent, induction regimen for stem-cell transplantation and as maintenance therapy Myeloma today: Disease definitions and treatment advances.Late relapses following reduced intensity allogeneic transplantation in patients with multiple myeloma: a long-term follow-up study Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma.Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial Outcomes of salvage autologous versus allogeneic hematopoietic cell transplantation for relapsed multiple myeloma after initial autologous hematopoietic cell transplantation.Stem cell transplantation for multiple myeloma: current and future status Melphalan: old and new uses of a still master drug for multiple myeloma.Targeted treatments to improve stem cell outcome: old and new drugs.Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCT Total marrow irradiation: a new ablative regimen as part of tandem autologous stem cell transplantation for patients with multiple myeloma.Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2012 Bortezomib in the front-line treatment of multiple myeloma.The role of high-dose chemotherapy followed by peripheral blood stem cell transplantation for the treatment of multiple myeloma.Current status of autologous hematopoietic stem cell transplantation in myeloma.Treatment of myeloma: cure vs control

P2860

Q24197999-D763C5EC-2F92-435A-81CE-281C82E98C94 Q24655964-B96C94FE-359D-4D1B-8ECE-400CE9DC118B Q26745957-23CD9C2F-B1C6-4EFD-9F07-718C86153A23 Q26824498-FFD40EB2-A128-4FF4-91F9-09D4CAF5E0DE Q26998884-9B1902D2-F70C-4922-8784-DA05DC283D98 Q27014801-A409EF7E-1542-4824-892E-96FEAB5C1C10 Q27024932-B324FA1E-1EF9-4DA6-B8AB-090828CB8FD2 Q30409713-4D00D759-FB7D-4870-BA1C-2F66D9594AAA Q30416452-8BBEF3DD-3066-49F6-A8B8-9AB7228DF371 Q30486842-C67B44D0-5296-40D8-90B3-175850B91184 Q33956059-80ADC13D-A7CF-4FAB-890C-04A20156E2F8 Q34019581-2FCCDB82-2039-462D-AA95-896001008F65 Q34316924-D65BB58F-75E5-4186-8863-4B015B337A8A Q34343036-2604B69A-2E44-47E4-9668-3CFA78081A5C Q34604658-9379F9E7-9FE4-479A-8452-FC901E3CBF40 Q34647698-39316DCD-3662-4A85-8C1D-170E302B082B Q35097338-0F1AC34B-3C23-4381-8170-39AC28D03A48 Q35569350-D0BA81FD-3368-40A0-997E-83D1AD821249 Q35651684-9133BCA0-AB51-4301-B486-7C549A79C6E0 Q35802414-359535A9-936D-44B8-B8F6-F4752E8BB8BB Q35944707-95B93402-97DC-41C3-A99B-33525A3A3D71 Q36014687-B4F0038D-7984-437C-8451-76B9A0160A36 Q36031316-A7CD6B12-8FC1-4D25-B340-012067D7DB46 Q36251560-D45B1C41-9107-4256-8B70-792CAE50398D Q36470699-D4A32EBB-AB33-4424-88CE-E93074B52DEE Q36524579-494F7975-5E0D-49F9-910F-FC27B9138A7E Q36541807-D2D182FB-F25E-4C66-BC40-DFFCBC192176 Q36725446-70995554-448E-493F-B596-8A069862624E Q36834629-64636D49-69B6-4A69-95F0-05A595CAC8BC Q36852229-7B466605-D2AF-4E44-8187-847054B6A61F Q36916889-36808131-DDA4-4949-8026-9F6A3787BF59 Q36927960-C9187703-4862-4674-8D34-E9D369ACA992 Q36963203-49AC19E1-6E25-4B32-A1E4-C1E73EA3E4A8 Q36973229-9D4D0998-CAA5-4DC6-9A4F-67EB6BE26E72 Q37030249-88B3EB4A-9A59-43FA-9909-BD3A3D02FF19 Q37057028-D04CB132-40B0-4E80-AE22-4EC870D5268B Q37202761-B379D149-1DEB-46EA-8410-6AC0759F225C Q37209935-EDFCFE6D-FFAA-4F8B-AD69-D70092CE893D Q37251047-28BC247A-6389-4161-8FC7-0D7DFFA6DD7F Q37284081-999099A1-293C-4C5A-B0FC-BA13306CDA7B

P2860

Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study

http://www.wikidata.org/entity/Q56995088

description

im Juni 2007 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2007

@uk

name

Prospective, randomized study ...... oma: Bologna 96 clinical study

@en

Prospective, randomized study ...... oma: Bologna 96 clinical study

@nl

type

label

Prospective, randomized study ...... oma: Bologna 96 clinical study

@en

Prospective, randomized study ...... oma: Bologna 96 clinical study

@nl

prefLabel

Prospective, randomized study ...... oma: Bologna 96 clinical study

@en

Prospective, randomized study ...... oma: Bologna 96 clinical study

@nl

P1433

Q56995088-8BF1F309-B365-4A0E-8A85-9AE284BB66A9

P1476

Q56995088-5E3F3D70-76E9-46A3-A628-2F5C8F48B698

P2093

Q56995088-0485ADE2-ACE2-407B-B951-EAEFA72D0691

Q56995088-0B98DD5B-49D0-47C9-B73C-16E878091BE0

Q56995088-13BEF94F-0232-4B3E-9B04-1B38B3BC30C7

Q56995088-28B57F09-9106-499D-8640-5EDFF51473D9

Q56995088-39E9921D-732F-40C7-AAAB-C8F817E11463

Q56995088-56774C3D-A4EC-4629-9AF4-8BC81ED4730F

Q56995088-57036AF9-6D9F-4882-B803-A2DBEE9984E9

Q56995088-64295010-69A7-428D-93E1-2A08A867666F

Q56995088-70875F94-97A4-4DF7-A782-BA81825DE0CC

Q56995088-82F09922-6CFD-44D0-AA01-36F6C05367D6

P304

Q56995088-BAF038DD-42D2-48F1-A356-95303984E6C8

P31

Q56995088-9E2B5F26-802F-4C1E-AA0F-AC4AD7397385

P356

Q56995088-B30EC7F3-7569-43F3-8638-D73867FBF147

P407

Q56995088-CA6B83EB-36BC-450D-BEC7-3BE8F20B96A4

P433

Q56995088-0D6B2FF5-B88B-4864-B34A-57B3474836C8

P478

Q56995088-74B155D0-48BE-49CB-9A54-AFC3AE0EEBD3

P50

Q56995088-4E6A4E24-8E1B-4C7B-B753-8056DA9E9806

Q56995088-65857BC4-005F-4568-BE08-2DD106FC8DF3

Q56995088-AC212421-0CDB-4BE9-90C9-C4EDC94AED39

Q56995088-F7EEE2DF-3A51-4DC7-8831-CCDC2A52C012

Q56995088-FE7382A7-3912-43F8-B720-5720AC4D4327

P577

Q56995088-ACA5A39A-E1D9-48EC-9C65-4E0DE2610A89

P698

Q56995088-18ACC254-F1EA-4EC8-91D3-526DEB48F128

P356

JCO.2006.10.2509

P1433

Journal of Clinical Oncology

P1476

Prospective, randomized study ...... oma: Bologna 96 clinical study

@en

P2093

Affra Carubelli

http://www.w3.org/2001/XMLSchema#string

Antonio Lazzaro

http://www.w3.org/2001/XMLSchema#string

Antonio de Vivo

http://www.w3.org/2001/XMLSchema#string

Claudia Cellini

http://www.w3.org/2001/XMLSchema#string

Delia Cangini

http://www.w3.org/2001/XMLSchema#string

Elena Zamagni

http://www.w3.org/2001/XMLSchema#string

Ettore Volpe

http://www.w3.org/2001/XMLSchema#string

Francesca Patriarca

http://www.w3.org/2001/XMLSchema#string

Luciano Masini

http://www.w3.org/2001/XMLSchema#string

Lucio Catalano

http://www.w3.org/2001/XMLSchema#string

P304

2434-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2006.10.2509

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Di Raimondo

Alessandro Gozzetti

Michele Baccarani

P577

2007-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17485707

http://www.w3.org/2001/XMLSchema#string